疾病修饰治疗对多发性硬化症患者的脂质参数的影响
Nizameddin Koca1, Meral Seferoğlu2
1University of Health Sciences, Bursa Sehir Training & Research Hospital, Department of Internal Medicine, Bursa, Turkey.
Multiple sclerosis and related disorders
|July 9, 2023
概括
这项研究发现,多发性硬化症 (MS) 患者的疾病修饰治疗 (DMT) 和胆固醇水平之间没有显著的联系. 尽管观察到一些变化,但在各种DMT (包括Fingolimod) 中,脂质样本基本不变,尽管观察到一些变化.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 临床神经学 临床神经学
背景情况:
- 胆固醇和脂质对神经细胞功能至关重要,特别是髓合成和稳定性.
- 血胆固醇升高可能与多发性硬化症 (MS) 的临床恶化有关.
- 关于疾病修饰疗法 (DMT) 对多发性硬化症患者脂质谱的影响的数据有限.
研究的目的:
- 为了研究各种DMT对多发性硬化症患者的血脂质概况的影响.
- 确定特定的DMT是否与胆固醇和脂质水平的变化有关.
主要方法:
- 对380名多发性硬化症患者的病历进行了回顾性分析.
- 在使用干扰素,格拉提拉默酸盐,芬戈利莫德,特里弗卢诺米德,二甲基烟酸盐,奥克雷利祖马布和对照组的患者中比较脂质谱.
- 收集的数据包括年龄,性别,疾病持续时间,EDSS分数和血清脂质水平.
主要成果:
- 总共分析了220名患者 (157名女性,63名男性).
- 平均年龄为39.83±10.21岁,平均疾病持续时间为8.45±6.56岁,平均EDSS得分为2.25±1.97.
- 虽然Fingolimod用户的脂质参数在数值上更高,但差异没有达到统计学意义.
结论:
- 在前六个月中,MS患者使用的DMT与他们的胆固醇水平之间没有统计学上显著的关系.
- 根据这项研究,目前的DMT似乎没有显著改变MS患者的血脂质谱.
- 可能需要进一步的研究来探索与MS治疗相关的微妙或长期脂质变化.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
702
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
702
01:26Atherosclerosis III: Management
13
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
13
01:24Overview of Lipid Metabolism
1.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.8K
01:26Coronary Artery Disease IV: Preventive Measures
25
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
200
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
200
01:21Rheumatic Heart Disease III: Medical Management
22
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
22